The effect of Epetraborole on the transcriptome and proteome of Escherichia coli strain overexpressing leuS, Leucyl-tRNA Synthetase

Anara BABAYEVA,Esra DİBEK,Deniz SÜNNETÇİ AKKOYUNLU,Naci ÇİNE,Murat KASAP,Gürler AKPINAR,Bekir ÇÖL
DOI: https://doi.org/10.51753/flsrt.1416938
2024-03-01
Frontiers in Life Sciences and Related Technologies
Abstract:Epetraborole (EP), a boron-containing antibiotic, is renowned for its efficacy against gram-negative enteric bacteria and Mycobacterium species. Commercially designed to bind and inhibit the LeuS enzyme (Leucyl-tRNA Synthetase), encoded by the essential gene leuS in E. coli, EP hinders protein translation, impeding bacterial growth. Consequently, LeuS serves as the target for EP antibiotics. However, when leuS is artificially overexpressed in a recombinant plasmid, the amount of EP required for growth inhibition needs to be increased. This investigation explores the impact of EP on the transcriptome and proteome of E. coli cells overexpressing leuS, aiming to reveal additional gene and pathway insights beyond LeuS, shedding light on the biochemical players orchestrating the bacterium's molecular response. Proteomics analysis, utilizing 2D-PAGE, identifies four differentially regulated protein spots influenced by EP in the leuS overexpression strain. Notably, LeuA and DeoA emerge as identified proteins. LeuA, the enzyme catalyzing the first step in leucine synthesis in E. coli, may be affected by the overexpression of LeuS, potentially leading to truncated LeuA protein variants. Transcriptomics analyses, based on microarray data, reveal 23 up-regulated and 9 down-regulated genes responding to EP in the overexpression strain (p2), p
English Else
What problem does this paper attempt to address?